Market Indices
Latest News
 |
| ||
| ||
| ||
Price Targets
from Northland Securities issued a price target of $70.00 for VEON on 2026-06-09 11:07:21.The adjusted price target was set to $70.00.At the time of the announcement, VEON...
June 9, 2026 VEON 0.88%
from CLSA issued a price target of $6.10 for MLCO on 2026-06-05 13:29:13.The adjusted price target was set to $6.10.At the time of the announcement, MLCO was...
June 5, 2026 MLCO -5.64%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| FRSX Foresight Autonomous Hold | 1.68
19.64% | ||||||||||||||||||
| ADXN Addex Therapeutics Ltd | 6.79
15.87% | ||||||||||||||||||
| LXEH Lixiang Education Holding | 1.37
13.22% | ||||||||||||||||||
| ATHE Alterity Therapeutics Lim | 4.24
8.30% | ||||||||||||||||||
| AKO-A Embotelladora Andina S.A. | 21.90
7.93% | ||||||||||||||||||
| DXF Eason Technology Limited | 0.62
7.83% | ||||||||||||||||||
| IXHL Incannex Healthcare Limit | 3.66
7.65% | ||||||||||||||||||
| QNRX Quoin Pharmaceuticals, Lt | 4.91
7.44% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 1.98%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 3.38%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA 3.38%